» Articles » PMID: 22920610

Primary Chordomas of the Cervical Spine: a Consecutive Series of 14 Surgically Managed Cases

Overview
Date 2012 Aug 28
PMID 22920610
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Object: Cervical chordomas are rare lesions and usually bring about challenges in treatment planning because of their wide extension and complicated adjacent anatomy. There are few large published series at present focusing on cervical chordomas. The authors studied a consecutive series of 14 patients with primary cervical chordomas who underwent surgical treatment and were observed between 1989 and 2008. By reviewing the clinical patterns and follow-up data, they sought to investigate the clinical characters, tailor the appropriate surgical techniques, and establish prognosis factors for cervical chordomas.

Methods: Hospitalization and follow-up data in the 14 patients were collected. All patients underwent piecemeal tumor excision and reconstruction for stability; total spondylectomy was achieved in 5 cases. Postoperative radiotherapy was administered in all patients. Kaplan-Meier plots were used to represent tumor recurrence and patient survival, and log-rank testing was used to determine the risk factors of local recurrence.

Results: Follow-up ranged from 8 to 120 months (mean 58.6 months). Symptom and neural status in most patients improved after surgery. The 1- and 5-year disease-free survival rates were 78.6% and 50%, respectively, and the 1- and 5-year survival rates were 92.9% and 85.7%, respectively. Log-rank tests revealed that the following variables were significantly associated with a high rate of tumor recurrence: age less than 40 years or greater than 70 years (p = 0.006) and an upper cervical tumor location (p = 0.019).

Conclusions: Chordomas in the cervical spine are usually neoplasms that exhibit insidious growth and a wide extension by the time of diagnosis. Radical intralesional debulking surgery and postoperative radiotherapy have been effective treatment. A limited application of en bloc tumor resection and the highly likely intraoperative intralesional tumor seeding may partially explain the high local recurrence rate, whereas the chance of distant metastases, fortunately, is very low. Most recurrence were documented within 3 years. Some specific surgical techniques should be emphasized to minimize tumor seeding. Patients with upper cervical chordomas, younger adults, and elderly adults have worse prognosis. For patients with chordoma extending to both the anterior and posterior spinal columns, total spondylectomy combined with piecemeal excision is recommended for a better prognosis.

Citing Articles

Extracellular Vesicles from a Novel Chordoma Cell Line, ARF-8, Promote Tumorigenic Microenvironmental Changes When Incubated with the Parental Cells and with Human Osteoblasts.

Nguyen K, Graner A, Fringuello A, Zizzo Z, Valenzuela L, Anyanwu K Int J Mol Sci. 2024; 25(23).

PMID: 39684443 PMC: 11641215. DOI: 10.3390/ijms252312731.


Parasagittal resection of multilevel cervical chordoma with autograft duraplasty and unilateral vertebral artery ligation: A case report and literature review.

Tavares Junior M, Morale V, Soares L, Teixeira W, Narazaki D Radiol Case Rep. 2024; 19(3):1181-1189.

PMID: 38259708 PMC: 10801135. DOI: 10.1016/j.radcr.2023.12.039.


Multifocal Ectopic Recurrence of a C2 Chordoma.

Reyes M, Kayne A, Collopy S, Prashant G, Kelly P, Evans J J Neurol Surg Rep. 2023; 84(4):e146-e155.

PMID: 38026145 PMC: 10673705. DOI: 10.1055/s-0043-1777073.


En bloc resection of a high cervical chordoma followed by reconstruction with a free vascularized fibular graft: illustrative case.

Pinter Z, Moore E, Rose P, Nassr A, Currier B J Neurosurg Case Lessons. 2022; 4(25).

PMID: 36536523 PMC: 9764371. DOI: 10.3171/CASE22305.


Long-term outcomes of high dose carbon-ion radiation therapy for unresectable upper cervical (C1-2) chordoma.

Aoki S, Koto M, Ikawa H, Imai R, Tokuhiko O, Shinoto M Head Neck. 2022; 44(10):2162-2170.

PMID: 35734902 PMC: 9544549. DOI: 10.1002/hed.27127.